The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.75
Bid: 6.50
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 0.50 (7.692%)
Open: 6.75
High: 6.75
Low: 6.75
Prev. Close: 6.75
HDD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funding and Annual Results Update

22 Dec 2022 07:00

RNS Number : 5405K
Hardide PLC
22 December 2022
 

22 December 2022

 

Hardide plc

("Hardide", "the Group" or "the Company")

 

Funding and Annual Results Update

 

Funding

 

Hardide plc (AIM: HDD), the developer and provider of advanced surface coating technology, is pleased to announce that further to the £0.5m equity fundraising in September, the Group has raised a further c.£0.5m in net cash proceeds from the purchase, sale and leaseback of its Martinsville facility in the USA. Accordingly, the Group has entered into a new 10 year lease for the site.

 

In addition, the Board has recently implemented a series of working capital efficiency and cost reduction initiatives. These are expected to generate a further £0.3m to £0.4m of cash over the next six months, providing additional working capital headroom whilst helping to underpin expectations of results for the financial year ending 30 September 2023. The Group maintains strong cost discipline and is focused on moving toward organic cash generation, but in the meantime will continue to explore options to raise additional funds to further improve its financial position.

 

Annual results

 

The Group expects to announce its annual results for the financial year to 30 September 2022 on 8 February 2023, following completion of the external audit.

 

In the meantime, the Board reiterates its expectation of revenues for the year to 30 September 2022 to be approximately £5.0m, an increase of almost 40% on the previous year as per the year end trading update of 13 October 2022. The Board also now expects to report an EBITDA loss of £0.9m (FY 2021: EBITDA loss of £1.5m), considerably better than the previous year in line with the Board's expectations and reflecting the improved revenue performance.

Revenue growth has continued in the new financial year, with the Group achieving record monthly revenues in November.

 

Enquiries:

Hardide plc

Andrew Magson, Non-Executive Chair

Philip Kirkham, CEO

Jackie Heddle, Communications Manager

 

Tel: +44 (0) 1869 353 830

IFC Advisory

Graham Herring

Tim Metcalfe

Florence Chandler

Tel: +44 (0) 20 3934 6630

finnCap - Nominated Adviser and Joint Broker

Henrik Persson/ Abigail Kelly (Corporate finance)

Barney Hayward (ECM/Broking)

Tel: +44 (0) 2072 200 500

 

Allenby Capital - Joint Broker

Tony Quirke - Sales and Corporate Broking

Jeremy Porter/ Freddie Wooding - Corporate Finance

 

Tel: +44 (0) 20 3328 5656

 

Notes to editors:

www.hardide.com

 

Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency. Customers include leading companies operating in the energy sectors, valve and pump manufacturing, industrial engineering and aerospace industries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFIAFTLLFIF
Date   Source Headline
7th Oct 20217:00 amRNSYear End Trading Update
9th Sep 20212:05 pmRNSSecond Price Monitoring Extn
9th Sep 20212:00 pmRNSPrice Monitoring Extension
9th Sep 20217:00 amRNSContract Award
14th Jul 20218:17 amRNSHolding(s) in Company
6th Jul 20217:00 amRNSNew Facility Receives Airbus Approval
5th Jul 20213:46 pmRNSHolding(s) in Company
7th Jun 202111:00 amRNSHolding(s) in Company
19th May 20215:37 pmRNSHolding(s) in Company
18th May 20217:00 amRNSInterim Results
28th Apr 20213:16 pmRNSHolding(s) in Company
19th Mar 20213:19 pmRNSHolding(s) in Company
15th Mar 202112:06 pmRNSResult of AGM
15th Mar 20217:00 amRNSAGM Statement
25th Feb 202110:22 amRNSIssue of Options
19th Feb 20215:01 pmRNSHolding(s) in Company
19th Feb 20217:00 amRNSNotice of AGM
5th Feb 20217:00 amRNSHolding(s) in Company
1st Feb 202110:50 amRNSResult of Fundraising
1st Feb 20217:00 amRNSProposed equity fundraising and CBILS loan
7th Dec 20207:00 amRNSPreliminary results for year ended 30 Sept 2020
23rd Sep 20207:00 amRNSPre-close Trading Update
3rd Aug 20205:24 pmRNSDirector Dealing - Correction
3rd Aug 202012:17 pmRNSDirector Dealing
23rd Jul 20207:00 amRNSResignation of Non-Executive Director
16th Jul 20207:00 amRNSTrading Update
25th Jun 20202:30 pmRNSExercise of Options
23rd Jun 20202:14 pmRNSHolding(s) in Company
17th Jun 20203:43 pmRNSChange of Registered Office
20th May 20204:37 pmRNSIssue of Options
19th May 20207:00 amRNSInterim Results
21st Apr 20207:00 amRNSQueen’s Award for Enterprise
14th Apr 20205:00 pmRNSExercise of Options
31st Mar 20207:00 amRNSTRADING UPDATE AND THE IMPACT OF COVID-19
17th Feb 202012:47 pmRNSResult of AGM
17th Feb 20207:00 amRNSAGM Statement
10th Feb 20207:00 amRNSPresenting at The Growth & Innovation Forum
27th Jan 20202:43 pmRNSHolding(s) in Company
27th Jan 20207:00 amRNSAppointment of Finance Director
21st Jan 20208:15 amRNSDirector/PDMR Shareholding
21st Jan 20207:00 amRNSPlacing to raise £2.5 million
16th Dec 20195:22 pmRNSGrant of Options
9th Dec 20197:00 amRNSPreliminary Results
13th Nov 20197:00 amRNSHardide approved for F-35 Joint Strike Fighter
11th Nov 20197:00 amRNSPatent Award
15th Oct 20198:23 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSTrading Update
23rd Aug 20197:00 amRNSAppointment of Joint Broker
21st Aug 20197:00 amRNSOrders for three new coating reactors
12th Aug 20198:17 amRNSHardide selected for Airbus A330 wing components

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.